These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37489058)

  • 1. Appropriateness of inpatient intravenous iron therapy in a Swiss tertiary care hospital.
    Ritter F; Staub BM; Osthoff M
    Eur J Haematol; 2023 Oct; 111(4):601-610. PubMed ID: 37489058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial impact of intravenous iron treatments on the management of anaemia inpatients: a 1 year observational study.
    Delpeuch A; Ruivard M; Abergel A; Aumaitre O; Boisgard S; Bagel S; Sautou V
    Int J Clin Pharm; 2018 Jun; 40(3):686-692. PubMed ID: 29520555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of antimicrobial prescribing in a Swiss tertiary care hospital: a repeated point prevalence survey.
    Gürtler N; Erba A; Giehl C; Tschudin-Sutter S; Bassetti S; Osthoff M
    Swiss Med Wkly; 2019 Oct; 149():w20135. PubMed ID: 31656037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
    Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
    Khalafallah AA; Yan C; Al-Badri R; Robinson E; Kirkby BE; Ingram E; Gray Z; Khelgi V; Robertson IK; Kirkby BP
    Lancet Haematol; 2016 Sep; 3(9):e415-25. PubMed ID: 27570088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron deficiency anemia in the emergency department: over-utilization of red blood cell transfusion and infrequent use of iron supplementation.
    Spradbrow J; Lin Y; Shelton D; Callum J
    CJEM; 2017 May; 19(3):167-174. PubMed ID: 27819205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review.
    Aksan A; Zepp F; Anand S; Stein J
    Eur J Pediatr; 2022 Nov; 181(11):3781-3793. PubMed ID: 36056175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis.
    Shin HW; Go DY; Lee SW; Choi YJ; Ko EJ; You HS; Jang YK
    Medicine (Baltimore); 2021 May; 100(20):e24571. PubMed ID: 34011020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease.
    Aksan A; Işık H; Radeke HH; Dignass A; Stein J
    Aliment Pharmacol Ther; 2017 May; 45(10):1303-1318. PubMed ID: 28326596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications and associated factors for prescribing intravenous iron supplementation in Swiss general practice: a retrospective observational study.
    Meier R; Keizer E; Rosemann T; Markun S
    Swiss Med Wkly; 2019 Sep; 149():w20127. PubMed ID: 31568551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
    Khoury A; Pagan KA; Farland MZ
    Ann Pharmacother; 2021 Feb; 55(2):222-229. PubMed ID: 32633548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
    Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
    Vanobberghen F; Lweno O; Kuemmerle A; Mwebi KD; Asilia P; Issa A; Simon B; Mswata S; Schmidlin S; Glass TR; Abdulla S; Daubenberger C; Tanner M; Meyer-Monard S
    Lancet Glob Health; 2021 Feb; 9(2):e189-e198. PubMed ID: 33245866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of iron deficiency anemia and iron deficiency in a pediatric population with inflammatory bowel disease.
    Carvalho FSG; de Medeiros IA; Antunes H
    Scand J Gastroenterol; 2017 Oct; 52(10):1099-1103. PubMed ID: 28643539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of iron deficiency with intravenous ferric carboxymaltose in general practice: a retrospective database study.
    Kuster M; Meli DN
    J Clin Med Res; 2015 Jan; 7(1):37-40. PubMed ID: 25368700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective review of effectiveness and safety of intravenous ferric carboxymaltose given to children with iron deficiency anaemia in one UK tertiary centre.
    Tan MLN; Windscheif PM; Thornton G; Gaynor E; Rodrigues A; Howarth L
    Eur J Pediatr; 2017 Oct; 176(10):1419-1423. PubMed ID: 28844092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The newest information for iron metabolism: ferric carboxymaltose, a recently available treatment option for iron-deficiency anemia].
    Ikuta K
    Rinsho Ketsueki; 2021; 62(5):388-396. PubMed ID: 34108319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study.
    Ikuta K; Ito H; Takahashi K; Masaki S; Terauchi M; Suzuki Y
    Int J Hematol; 2019 Jan; 109(1):50-58. PubMed ID: 30194568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.
    Froessler B; Gajic T; Dekker G; Hodyl NA
    Arch Gynecol Obstet; 2018 Jul; 298(1):75-82. PubMed ID: 29740690
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.